295 related articles for article (PubMed ID: 10613340)
1. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.
Lacey JV; Brinton LA; Abbas FM; Barnes WA; Gravitt PE; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Silverberg SG; Hildesheim A
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1079-85. PubMed ID: 10613340
[TBL] [Abstract][Full Text] [Related]
2. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
[TBL] [Abstract][Full Text] [Related]
3. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix.
Lacey JV; Brinton LA; Barnes WA; Gravitt PE; Greenberg MD; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Kurman RJ; Hildesheim A
Gynecol Oncol; 2000 Apr; 77(1):149-54. PubMed ID: 10739704
[TBL] [Abstract][Full Text] [Related]
4. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix.
Lacey JV; Swanson CA; Brinton LA; Altekruse SF; Barnes WA; Gravitt PE; Greenberg MD; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Kurman RJ; Hildesheim A
Cancer; 2003 Aug; 98(4):814-21. PubMed ID: 12910527
[TBL] [Abstract][Full Text] [Related]
5. [Cancer of the cervix, papillomavirus, contraception and tobacco].
Thiry L; Vokaer R; Detremmerie O; De Schepper N; Herzog A; Bollen A
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):477-86. PubMed ID: 8228010
[TBL] [Abstract][Full Text] [Related]
6. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
7. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women.
Sasagawa T; Basha W; Yamazaki H; Inoue M
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):45-52. PubMed ID: 11205488
[TBL] [Abstract][Full Text] [Related]
8. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972
[TBL] [Abstract][Full Text] [Related]
9. A population-based study of squamous cell vaginal cancer: HPV and cofactors.
Daling JR; Madeleine MM; Schwartz SM; Shera KA; Carter JJ; McKnight B; Porter PL; Galloway DA; McDougall JK; Tamimi H
Gynecol Oncol; 2002 Feb; 84(2):263-70. PubMed ID: 11812085
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.
Madeleine MM; Daling JR; Schwartz SM; Shera K; McKnight B; Carter JJ; Wipf GC; Critchlow CW; McDougall JK; Porter P; Galloway DA
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):171-7. PubMed ID: 11303584
[TBL] [Abstract][Full Text] [Related]
11. Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing.
Andersson S; Rylander E; Larson B; Sigurdardottir S; Backlund I; Sällström J; Wilander E
Oncol Rep; 2003; 10(1):175-9. PubMed ID: 12469166
[TBL] [Abstract][Full Text] [Related]
12. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.
Hildesheim A; Herrero R; Castle PE; Wacholder S; Bratti MC; Sherman ME; Lorincz AT; Burk RD; Morales J; Rodriguez AC; Helgesen K; Alfaro M; Hutchinson M; Balmaceda I; Greenberg M; Schiffman M
Br J Cancer; 2001 May; 84(9):1219-26. PubMed ID: 11336474
[TBL] [Abstract][Full Text] [Related]
13. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
14. [The relationship with human papilloma virus DNA in cervical adenocarcinoma].
Ogura K; Ishi K; Suzuki F; Suto H; Kina K; Koyatsu J; Nojima M; Yoshida K; Suda K
Rinsho Byori; 2004 Feb; 52(2):115-9. PubMed ID: 15027314
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of cervical cancer by cell type.
Brinton LA; Tashima KT; Lehman HF; Levine RS; Mallin K; Savitz DA; Stolley PD; Fraumeni JF
Cancer Res; 1987 Mar; 47(6):1706-11. PubMed ID: 3815368
[TBL] [Abstract][Full Text] [Related]
16. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix.
Burk RD; Terai M; Gravitt PE; Brinton LA; Kurman RJ; Barnes WA; Greenberg MD; Hadjimichael OC; Fu L; McGowan L; Mortel R; Schwartz PE; Hildesheim A
Cancer Res; 2003 Nov; 63(21):7215-20. PubMed ID: 14612516
[TBL] [Abstract][Full Text] [Related]
17. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ.
Ylitalo N; Josefsson A; Melbye M; Sörensen P; Frisch M; Andersen PK; Sparén P; Gustafsson M; Magnusson P; Pontén J; Gyllensten U; Adami HO
Cancer Res; 2000 Nov; 60(21):6027-32. PubMed ID: 11085523
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type distribution in cervical cancer in Delhi, India.
Bhatla N; Dar L; Patro AR; Kriplani A; Gulati A; Verma K; Broor S; Shah KV; Gravitt PE
Int J Gynecol Pathol; 2006 Oct; 25(4):398-402. PubMed ID: 16990719
[TBL] [Abstract][Full Text] [Related]
19. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
[TBL] [Abstract][Full Text] [Related]
20. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
